UnknownNot applicableNCT04882046
Study of the Incidence of Jarisch-Herxheimer Reaction in Leptospirosis Patients in New Caledonia
Studying Leptospirosis
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Institut Pasteur
- Principal Investigator
- Julie CAGLIERO, PhDInstitut Pasteur de Nouvelle-Calédonie
- Intervention
- Blood collection(other)
- Enrollment
- 900 enrolled
- Eligibility
- 18 years · All sexes
- Timeline
- 2021 – 2023
Study locations (5)
- Centre Médico-Social Jeanne Boutin, Bourail, Nouvelle Calédonie, New Caledonia
- Centre hospitalier Territorial Gaston-Bourret, Noumea, Nouvelle Calédonie, New Caledonia
- Centre hospitalier du Nord, Koné, New Caledonia
- Centre hospitalier du Nord, Koumac, New Caledonia
- Centre hospitalier du Nord, Poindimié, New Caledonia
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT04882046 on ClinicalTrials.govOther trials for Leptospirosis
Additional recruiting or active studies for the same condition.
- RECRUITINGPHASE2NCT07127718Preventive Strategies for Early and Late Complications of LeptospirosisNational Kidney and Transplant Institute, Philippines
- RECRUITINGNANCT05436756Chronic Post-leptospirosis Manifestations in ReunionCentre Hospitalier Universitaire de la Réunion
- ACTIVE NOT RECRUITINGNANCT04034550Cohort of Hospitalized Patients Suspected of LeptospirosisInstitut National de la Santé Et de la Recherche Médicale, France
- RECRUITINGNCT04288674Leptospirosis Registry - LeptoScopeUniversity of Cologne
- RECRUITINGNANCT05425524Leptospirosis Care Bundle StudyChulalongkorn University